These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 21294383)
1. Implication of pneumococcal conjugate vaccines to public health: Thailand perspective. Wongsawat J; Chokephaibulkit K J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S53-60. PubMed ID: 21294383 [TBL] [Abstract][Full Text] [Related]
2. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related]
3. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773 [TBL] [Abstract][Full Text] [Related]
4. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516 [TBL] [Abstract][Full Text] [Related]
7. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006. Motlova J; Benes C; Kriz P Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171 [TBL] [Abstract][Full Text] [Related]
8. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
9. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924 [TBL] [Abstract][Full Text] [Related]
10. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
11. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389 [TBL] [Abstract][Full Text] [Related]
13. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Aguiar SI; Brito MJ; Gonçalo-Marques J; Melo-Cristino J; Ramirez M Vaccine; 2010 Jul; 28(32):5167-73. PubMed ID: 20558247 [TBL] [Abstract][Full Text] [Related]
15. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae? Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966 [TBL] [Abstract][Full Text] [Related]
16. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357 [TBL] [Abstract][Full Text] [Related]
18. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. Gladstone RA; Jefferies JM; Faust SN; Clarke SC Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969 [TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
20. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]